Skip to main content

Table 2 Genetic properties of patient Env clones

From: Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C envclones obtained at different time points from antiretroviral naïve Indian patients with recent infection

Patient ID

Clone ID/Follow up Schedule†

Source

gp120 length

gp41 length

PNLG sites

Net V3 loop charge

CoR usage

 

2.J8/B

PBMC

466

352

25

3

CCR5

 

2.J9/B

PBMC

466

352

26

3

CCR5

 

2-3.J4/F1

PLASMA

465

352

30

3

CCR5

NARI-IVC2

2-3.J7/F1

PLASMA

466

352

29

3

CCR5

 

2-3.J17/F1

PLASMA

460

352

28

3

CCR5

 

2-3.J18/F1

PLASMA

465

352

30

3

CCR5

 

2-5.J3/F2

PLASMA

466

345

31

3

CCR5

 

2-5.J11/F2

PLASMA

465

352

29

2

CCR5

 

3.J16/B

PBMC

466

352

27

5

CCR5

NARI-IVC3

3-3.J9/F1

PLASMA

459

352

28

5

CCR5

 

3-5.J25/F2

PLASMA

458

352

29

4

CCR5

 

3-5.J38/F2

PLASMA

463

352

31

3

CCR5

 

4.J2/B

PBMC

462

352

30

3

CCR5

 

4.J22/B

PBMC

462

352

30

3

CCR5

 

4.J27/B

PLASMA

461

352

29

3

CCR5

 

4-2.J41/F1

PLASMA

458

352

27

2

CCR5

 

4-2.J45/F1

PLASMA

460

345

27

2

CCR5

NARI-IVC4

4-2.J42b/F1

PLASMA

464

345

27

2

CCR5

 

4-2.J45b/F1

PLASMA

459

345

26

2

CCR5

 

4-2.J46b/F1

PLASMA

464

345

28

2

CCR5

 

4-2.J47b/F1

PLASMA

459

345

27

2

CCR5

 

4-5.J5/F2

PLASMA

455

345

28

2

CCR5

 

5.J41/B

PBMC

472

351

29

2

CCR5

 

5-3.J2/F1

PLASMA

461

351

26

3

CCR5

 

5-3.J4/F1

PLASMA

472

351

29

3

CCR5

 

5-3.J5/F1

PLASMA

461

362

30

3

CCR5

 

5-3.J9/F1

PLASMA

472

351

29

3

CCR5

NARI-IVC5

5-4.J16/F2

PLASMA

464

351

31

3

CCR5

 

5-4.J18/F2

PLASMA

475

351

30

4

CCR5

 

5-4.J22/F2

PLASMA

464

351

28

3

CCR5

 

5-4.J49/F2

PLASMA

475

351

30

3

CCR5

 

11.J25/B

PBMC

461

352

27

4

CCR5

 

11.J28/B

PBMC

461

352

27

4

CCR5

 

11-3.J3/F1

PLASMA

458

352

28

4

CCR5

NARI-IVC11

11-3.J9/F1

PLASMA

457

352

27

4

CCR5

 

11-3.J16/F1

PLASMA

457

352

26

4

CCR5

 

11-5.J12/F2

PLASMA

461

352

28

3

CCR5

  1. † B = Baseline sample; F1 = First Follow up and F2 = Second follow up.